» Articles » PMID: 38337756

Ventilator-Associated Pneumonia in the Neonatal Intensive Care Unit-Incidence and Strategies for Prevention

Overview
Specialty Radiology
Date 2024 Feb 10
PMID 38337756
Authors
Affiliations
Soon will be listed here.
Abstract

The second most prevalent healthcare-associated infection in neonatal intensive care units (NICUs) is ventilator-associated pneumonia (VAP). This review aims to update the knowledge regarding the incidence of neonatal VAP and to summarize possible strategies for prevention. The VAP incidence ranges from 1.4 to 7 episodes per 1000 ventilator days in developed countries and from 16.1 to 89 episodes per 1000 ventilator days in developing countries. This nosocomial infection is linked to higher rates of illness, death, and longer hospital stays, which imposes a substantial financial burden on both the healthcare system and families. Due to the complex nature of the pathophysiology of VAP, various approaches for its prevention in the neonatal intensive care unit have been suggested. There are two main categories of preventative measures: those that attempt to reduce infections in general (such as decontamination and hand hygiene) and those that target VAP in particular (such as VAP care bundles, head of bed elevation, and early extubation). Some of the interventions, including practicing good hand hygiene and feeding regimens, are easy to implement and have a significant impact. One of the measures that seems very promising and encompasses a lot of the preventive measures for VAP are the bundles. Some preventive measures still need to be studied.

Citing Articles

Effect of taurine supplementation on preventing ventilator-associated pneumonia in pediatrics under mechanical ventilation, a randomized controlled double-blind clinical trial.

Shirzad-Yazdi N, Shorafa E, Abootalebi S, Heidari R, Hojabri K, Doostfatemeh M Front Pediatr. 2025; 12:1490247.

PMID: 39867697 PMC: 11757258. DOI: 10.3389/fped.2024.1490247.


Tracheal tube infections in critical care: A narrative review of influencing factors, microbial agents, and mitigation strategies in intensive care unit settings.

Motallebirad T, Mohammadi M, Jadidi A, Safarabadi M, Kerami A, Azadi D SAGE Open Med. 2024; 12:20503121241306951.

PMID: 39691863 PMC: 11650591. DOI: 10.1177/20503121241306951.


Use of mucolytics and inhaled antibiotics in the NICU.

Gipsman A, Bhandari A, Bhandari V J Perinatol. 2024; 45(1):5-12.

PMID: 39562833 PMC: 11711088. DOI: 10.1038/s41372-024-02178-w.

References
1.
Branson R . The ventilator circuit and ventilator-associated pneumonia. Respir Care. 2005; 50(6):774-85. View

2.
Danchaivijitr S, Assanasen S, Apisarnthanarak A, Judaeng T, Pumsuwan V . Effect of an education program on the prevention of ventilator-associated pneumonia: A multicenter study. J Med Assoc Thai. 2006; 88 Suppl 10:S36-41. View

3.
Azab S, Sherbiny H, Saleh S, Elsaeed W, Elshafiey M, Siam A . Reducing ventilator-associated pneumonia in neonatal intensive care unit using "VAP prevention Bundle": a cohort study. BMC Infect Dis. 2015; 15:314. PMC: 4527219. DOI: 10.1186/s12879-015-1062-1. View

4.
van den Akker C, van Goudoever J, Szajewska H, Embleton N, Hojsak I, Reid D . Probiotics for Preterm Infants: A Strain-Specific Systematic Review and Network Meta-analysis. J Pediatr Gastroenterol Nutr. 2018; 67(1):103-122. DOI: 10.1097/MPG.0000000000001897. View

5.
Hocevar S, Edwards J, Horan T, Morrell G, Iwamoto M, Lessa F . Device-associated infections among neonatal intensive care unit patients: incidence and associated pathogens reported to the National Healthcare Safety Network, 2006-2008. Infect Control Hosp Epidemiol. 2012; 33(12):1200-6. DOI: 10.1086/668425. View